Hopewell, NJ, United States of America

Joel Goldstein

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 541(Granted Patents)


Location History:

  • Piscataway, NJ (US) (2002 - 2004)
  • Edison, NJ (US) (1998 - 2008)
  • Hopewell, NJ (US) (2020 - 2022)

Company Filing History:


Years Active: 1998-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Joel Goldstein: A Visionary in Antibody Innovation

Introduction

Joel Goldstein, a prominent inventor based in Hopewell, NJ, has made significant strides in the field of biotechnology, particularly in the development of innovative antibody-based therapies. With a remarkable portfolio of 12 patents, Goldstein's work has the potential to transform medical treatments and enhance immune responses in patients.

Latest Patents

Among his latest innovations are the anti-CD27 and anti-PD-L1 antibodies and bispecific constructs. These patents describe unique methods and constructs that involve anti-CD27 and anti-PD-L1 antibodies, along with their binding domains. Goldstein’s work emphasizes the development of bispecific constructs that link an anti-CD27 binding domain to an anti-PD-L1 binding domain. This innovation not only stimulates T cell activity but also enhances immune responses, providing valuable methods for treating various diseases and conditions.

Career Highlights

Goldstein has had a distinguished career, contributing to groundbreaking advancements in immunotherapy. His experience includes working with reputable companies such as Celldex Therapeutics Limited and Medarex Inc., where he collaborated on pivotal projects aimed at harnessing the body’s immune system to combat diseases.

Collaborations

Throughout his career, Goldstein has collaborated with notable professionals such as Tibor P. Keler and Yashwant M. Deo. These partnerships have strengthened the research and development of innovative treatments, showcasing the importance of teamwork in driving scientific advancements.

Conclusion

With his impressive collection of patents and a rich career in biotechnology, Joel Goldstein continues to be a leading figure in the development of innovative therapeutic strategies. His contributions in the field of antibodies have the potential to significantly impact patient healthcare and medical research, underlining the essential role of inventors in advancing science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…